The potential of xenotransplants.
Bollinger
R R
RR
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
D000818:Animals; D016026:Bone Marrow Transplantation; D002240:Carbohydrate Sequence; D002678:Chimera; D004187:Disaccharides / Q000276:immunology; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology / Q000639:trends*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods / Q000639:trends; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008969:Molecular Sequence Data; D011323:Primates; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology / Q000639:trends*
D004187:Disaccharides; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; C055075:galactosyl-(1-3)galactose